triamterene has been researched along with Benign Paroxysmal Peritonitis in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KATO, E | 1 |
| OSAWA, S | 1 |
| WAKASUGI, A | 1 |
| KIRIU, Y | 1 |
| ATO, T | 1 |
| MITSUNO, K | 1 |
| ITAZU, Y | 1 |
| Clancy, RL | 1 |
| Stiel, JN | 1 |
2 other studies available for triamterene and Benign Paroxysmal Peritonitis
| Article | Year |
|---|---|
[CLINICAL TRIALS OF THE NEW ALDOSTERONE ANTAGONISTS OF A STEROID NATURE].
Topics: Adolescent; Chronic Disease; Diabetes Mellitus; Extremities; Familial Mediterranean Fever; Geriatric | 1964 |
Familial Mediterranean fever with amyloidosis.
Topics: Adult; Amyloid; Amyloidosis; Bendroflumethiazide; Blood Proteins; Diet Therapy; Electrophoresis; Eth | 1968 |